Skip to content
value.today

PaxVax Inc

🇺🇸 San Diego, California, USAPharmaceuticalsFounded 2006
Total raised
$72 M
3 rounds on record
Latest round
$35 M
Dec 2013
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of PaxVax Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2013$35 MNo. 3$10 to $50 million

PaxVax Inc: Raise no. 3, Dec 2013

Investors in this round

9 investors had bought by the notice of Aug 11, 2014: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Common Stock and Series B Preferred Stock and the Common Stock issuable upon conversion thereof
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth J. Kelley · Executive Officer, Director
  • Henry G. Coit, Jr. · Director
  • Howard B. Rosen · Director
  • James B. Connolly · Director
  • Phil B. Russell · Director
  • Richard B. Tong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth J. Kelley, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 11, 2014. Read the notice at the SEC.

equitySEC
Nov 2010$35 MNo. 2$10 to $50 million

PaxVax Inc: Raise no. 2, Nov 2010

Investors in this round

19 investors had bought by the notice of Oct 1, 2013: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Securities offered consist of promissory notes convertible into shares of convertible preferred stock and the common stock underlying the convertible preferred stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth J. Kelley · Executive Officer, Director
  • Henry G. Coit, Jr. · Director
  • Howard B. Rosen · Director
  • Phil B. Russell · Director
  • Richard B. Tong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Kelley, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 1, 2013. Read the notice at the SEC.

debt, optionsSEC
Oct 2009$2 MNo. 1$2 to $10 million

PaxVax Inc: Raise no. 1, Oct 2009

Investors in this round

2 investors had bought by the notice of Nov 6, 2009: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $6 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Janine M. Taylor · Executive Officer
  • Kenneth J. Kelley · Executive Officer, Director
  • Howard B. Rosen · Director
  • Rennie J. Coit · Director
  • Richard B. Tong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Janine M. Taylor, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 6, 2009. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • PaxVax Inc chose not to state its revenue in its newest notice of a funding round (Aug 2014).

    SEC Form D · Aug 2014

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Aug 2014

That is all the official record says: PaxVax Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website did not answer.

Investors#

No investor of PaxVax Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by PaxVax Inc
NameRoleNamed in
Kenneth J. KelleyExecutive officerAug 2014
Janine M. TaylorExecutive officerNov 2010
Henry G. Coit, Jr.DirectorAug 2014
Howard B. RosenDirectorAug 2014
James B. ConnollyDirectorAug 2014
Kenneth J. KelleyDirectorAug 2014
Phil B. RussellDirectorAug 2014
Richard B. TongDirectorAug 2014
Rennie J. CoitDirectorNov 2009

About

Company in Redwood City, United States.